---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-001491"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:06:35.350296+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Maeve O'Meara resigns effective Jan 1, 2025; Gabriel Ling to become independent director

## Summary
- Maeve O'Meara notified board of her resignation as director for personal reasons, effective January 1, 2025.
- Resignation is not the result of any disagreement with the company, board, or operations.
- Board determined that existing director Gabriel Ling will qualify as independent as of the Effective Date.
- After the departure, a majority of independent directors will remain on the board.

## SEC filing metadata
- accession: 0001079973-24-001491
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/0001079973-24-001491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-001491
- JSON: https://secwatch.observer/filing/0001079973-24-001491.json
- Plain text: https://secwatch.observer/filing/0001079973-24-001491.txt

## Key facts
- Executive change
  Maeve O'Meara resigned as Director at Oncology Institute, Inc..
  - Action: resigned
  - Role: Director
  source text: On November 8, 2024, Maeve O’Meara notified the Board of Directors of The Oncology Institute, Inc. (the “Company”) of her intention to resign as a director of the Company for personal reasons, effective as of January 1, 2025 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997324001491/0001079973-24-001491-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.